乌司他丁与奥曲肽治疗急性胰腺炎的经济学评价
Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis
-
摘要: 目的 评价国产乌司他丁(天普洛安)与进口奥曲肽(善宁)治疗轻症急性胰腺炎的经济效果.方法 回顾41例轻症急性胰腺炎患者,按治疗药物的不同分为乌司他丁组、进口奥曲肽(善宁)组,运用药物经济学中的最小成本分析方法进行评价.结果 两组治疗效果差异无显著性,但进口奥曲肽组的治疗费用明显高于乌司他丁组.结论 国产乌司他丁治疗急性胰腺炎费用低,效果满意.Abstract: Objective To evaluate the economic effectiveness of domestic ulinastatin and sandostain in the treatment of acute pancreatitis. Methods 41 cases with acute pancreatitis were divided into 2 groups according to the therapeutic drug: the ulinastatin group and the sandostain group. The two groups were compared by cost-minimization analysis of pharmacoeconomics. Results There is no significant difference in clinical therapeutic effect between two groups, but the cost of the sandostain group is much higher than the ulinastatin group. Conclusion The cost of domestic ulinastatin is minimization.
-
Key words:
- ulinastatin /
- sandostain /
- pancreatitis /
- acute /
- cost-minimization analysis
计量
- 文章访问数: 2229
- HTML全文浏览量: 212
- PDF下载量: 382
- 被引次数: 0